{
    "title": "AstraZeneca shares fall on \"hefty\" $39-billion Alexion deal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-9050737/AstraZeneca-shares-fall-39-billion-Alexion-bill.html",
    "date": "2020-12-14",
    "keywords": [
        "deal",
        "share",
        "alexion",
        "price",
        "company",
        "soriot",
        "aripaka",
        "market",
        "bid",
        "portfolio",
        "dec",
        "monday",
        "acquisition",
        "weekend",
        "year",
        "cash",
        "worth",
        "equity",
        "premium",
        "liberum",
        "quality",
        "astrazeneca",
        "pence",
        "gmt",
        "value",
        "bet",
        "raredisease",
        "immunology",
        "drug",
        "push",
        "cancer",
        "tag",
        "room",
        "saturday",
        "result",
        "bidder",
        "bidding",
        "war",
        "pressure",
        "hedge",
        "fund",
        "elliott",
        "management",
        "sale",
        "helm",
        "httpswwwastrazenecacomourcompanyleadershiphtml",
        "success",
        "peak",
        "july",
        "race",
        "covid19",
        "pushkala",
        "aniruddha",
        "ghosh",
        "bengaluru",
        "editing",
        "koyyur",
        "patrick",
        "graham"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}